Kipp Weiskopf

The CD47-signal regulatory protein alpha (SIRPa) interaction is a therapeutic target for human solid tumors

Stephen B. Willingham, Jens-Peter Volkmer, Andrew J. Gentles et al. · Proceedings of the National Academy of Sciences · 2012 · 1.6K citations · Full text

Calreticulin Is the Dominant Pro-Phagocytic Signal on Multiple Human Cancers and Is Counterbalanced by CD47

Mark P. Chao, Siddhartha Jaiswal, Rachel Weissman-Tsukamoto et al. · Science Translational Medicine · 2010 · 750 citations

Anti-CD47 antibody–mediated phagocytosis of cancer by macrophages primes an effective antitumor T-cell response

Diane Tseng, Jens-Peter Volkmer, Stephen B. Willingham et al. · Proceedings of the National Academy of Sciences · 2013 · 629 citations · Full text

Engagement of MHC class I by the inhibitory receptor LILRB1 suppresses macrophages and is a target of cancer immunotherapy

Amira Barkal, Kipp Weiskopf, Kevin S. Kao et al. · Nature Immunology · 2017 · 533 citations · Full text

Cancer Immunosurveillance, Mhc Class, Immunology +8

Engineered SIRPα Variants as Immunotherapeutic Adjuvants to Anticancer Antibodies

Kipp Weiskopf, Aaron M. Ring, Chia Chi M. Ho et al. · Science · 2013 · 481 citations · Full text

Cancer Immunosurveillance, Cd47 Antagonist, Immunoengineering +14